IL33 and non-small cell lung carcinoma: Overexpression of IL-33 by transfection into NSCLC cells isolated from patients [91] and treatment of human lung A549 cells with IL-33 [92] enhanced tumor outgrowth, migration, invasion, and metastasis in an ST2-dependent manner.